 Hannah Zlotnick
Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Engineering | 8 | 2025 | 441 | 2.100 |
Why?
| | Lab-On-A-Chip Devices | 2 | 2026 | 60 | 1.800 |
Why?
| | Cartilage, Articular | 6 | 2022 | 343 | 0.990 |
Why?
| | Orthopedics | 2 | 2025 | 168 | 0.920 |
Why?
| | Synovial Membrane | 1 | 2026 | 124 | 0.870 |
Why?
| | Magnetic Phenomena | 1 | 2020 | 11 | 0.660 |
Why?
| | Fibroblasts | 1 | 2026 | 1019 | 0.640 |
Why?
| | Osteogenesis | 1 | 2022 | 207 | 0.640 |
Why?
| | Social Capital | 1 | 2020 | 6 | 0.630 |
Why?
| | Endothelial Cells | 1 | 2026 | 864 | 0.620 |
Why?
| | Hydrogels | 6 | 2025 | 703 | 0.440 |
Why?
| | Patient Readmission | 2 | 2020 | 765 | 0.440 |
Why?
| | Tissue Scaffolds | 5 | 2023 | 223 | 0.400 |
Why?
| | Nanofibers | 2 | 2023 | 24 | 0.370 |
Why?
| | Trypsin | 3 | 2021 | 75 | 0.340 |
Why?
| | Osteoarthritis | 2 | 2026 | 196 | 0.340 |
Why?
| | Cartilage | 2 | 2020 | 198 | 0.280 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2019 | 317 | 0.250 |
Why?
| | Animals | 11 | 2026 | 37948 | 0.240 |
Why?
| | Capsules | 2 | 2023 | 42 | 0.230 |
Why?
| | Hyaluronic Acid | 2 | 2025 | 223 | 0.220 |
Why?
| | Interleukin-1beta | 1 | 2026 | 390 | 0.200 |
Why?
| | Medicare | 2 | 2020 | 899 | 0.200 |
Why?
| | Intervertebral Disc | 1 | 2023 | 36 | 0.200 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2023 | 33 | 0.200 |
Why?
| | Materials Testing | 1 | 2025 | 349 | 0.200 |
Why?
| | Intervertebral Disc Displacement | 1 | 2023 | 41 | 0.190 |
Why?
| | Chondrogenesis | 2 | 2021 | 88 | 0.190 |
Why?
| | Platelet-Derived Growth Factor | 2 | 2021 | 85 | 0.190 |
Why?
| | Bone and Bones | 2 | 2022 | 317 | 0.180 |
Why?
| | Extracellular Matrix | 1 | 2026 | 560 | 0.170 |
Why?
| | Trapezium Bone | 1 | 2021 | 7 | 0.170 |
Why?
| | Carpal Bones | 1 | 2021 | 17 | 0.170 |
Why?
| | Fractures, Stress | 1 | 2021 | 31 | 0.170 |
Why?
| | Arthroplasty, Replacement | 1 | 2021 | 47 | 0.160 |
Why?
| | Diffusion | 1 | 2020 | 124 | 0.160 |
Why?
| | Fractures, Cartilage | 1 | 2019 | 5 | 0.150 |
Why?
| | Eligibility Determination | 1 | 2020 | 72 | 0.150 |
Why?
| | Biocompatible Materials | 1 | 2023 | 436 | 0.140 |
Why?
| | Iatrogenic Disease | 1 | 2019 | 73 | 0.140 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2019 | 97 | 0.140 |
Why?
| | Biological Products | 1 | 2021 | 256 | 0.130 |
Why?
| | Medicaid | 1 | 2020 | 464 | 0.110 |
Why?
| | Dementia | 1 | 2020 | 319 | 0.110 |
Why?
| | Patient Safety | 1 | 2019 | 353 | 0.110 |
Why?
| | Humans | 10 | 2026 | 144665 | 0.110 |
Why?
| | Hospitals | 1 | 2019 | 729 | 0.100 |
Why?
| | Cells, Cultured | 1 | 2020 | 4110 | 0.100 |
Why?
| | Disease Models, Animal | 1 | 2022 | 4539 | 0.090 |
Why?
| | Risk Assessment | 1 | 2020 | 3729 | 0.080 |
Why?
| | Cohort Studies | 1 | 2020 | 5957 | 0.070 |
Why?
| | Aged, 80 and over | 1 | 2020 | 8283 | 0.060 |
Why?
| | United States | 2 | 2020 | 16018 | 0.060 |
Why?
| | Goats | 1 | 2023 | 18 | 0.050 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2023 | 253 | 0.050 |
Why?
| | Tendons | 1 | 2023 | 129 | 0.040 |
Why?
| | Printing, Three-Dimensional | 1 | 2023 | 101 | 0.040 |
Why?
| | Transforming Growth Factor beta3 | 1 | 2021 | 15 | 0.040 |
Why?
| | Chemokine CXCL12 | 1 | 2021 | 86 | 0.040 |
Why?
| | Horses | 1 | 2021 | 203 | 0.040 |
Why?
| | Aged | 1 | 2020 | 25955 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2019 | 75 | 0.040 |
Why?
| | Models, Animal | 1 | 2021 | 393 | 0.040 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2019 | 195 | 0.040 |
Why?
| | Swine | 1 | 2021 | 828 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2019 | 317 | 0.030 |
Why?
| | Drug Carriers | 1 | 2019 | 132 | 0.030 |
Why?
| | Rabbits | 1 | 2019 | 651 | 0.030 |
Why?
| | Chondrocytes | 1 | 2019 | 232 | 0.030 |
Why?
| | Cattle | 1 | 2019 | 975 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2019 | 335 | 0.030 |
Why?
| | Peptides | 1 | 2021 | 989 | 0.030 |
Why?
| | Program Evaluation | 1 | 2019 | 941 | 0.030 |
Why?
| | Cell Movement | 1 | 2019 | 959 | 0.030 |
Why?
| | Male | 1 | 2020 | 72425 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2019 | 2489 | 0.020 |
Why?
| | Female | 1 | 2020 | 78301 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2019 | 17147 | 0.010 |
Why?
| | Adult | 1 | 2021 | 40486 | 0.010 |
Why?
|
|
Zlotnick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|